Contineum Therapeutics, Inc. Class A Common StockCTNMNASDAQ
Loading
Current Ratio Over TimeElevated
Percentile Rank100
3Y CAGR+62.5%
Studio
Year-over-Year Change

Current ratio (current assets / current liabilities)

3Y CAGR
+62.5%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
4.3x
Strong expansion
Streak
1 yr
Consecutive growthElevated
PeriodValueYoY Change
202527.50+32.9%
202420.69-11.1%
202323.29+263.3%
20226.41-66.3%
202118.99-